Literature DB >> 10695469

Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant?

H Kalla1, G X Yan, R Marinchak.   

Abstract

Recurrent ventricular fibrillation was observed in a 29-year-old Vietnamese man who did not exhibit structural heart disease. The patient's ECG showed prominent J (Osborn) waves and ST segment elevation in the inferior leads that were not associated with hypothermia, serum electrolyte disturbance, or myocardial ischemia. Rate-dependent change in the amplitude of J waves and ST segment elevation also were observed. An implantable cardioverter defibrillator (ICD) was implanted. Adjunctive treatment with amiodarone reduced J wave amplitude, preventing ventricular fibrillation and ICD shocks. Prominent J waves and ST segment elevation in the inferior leads may serve as an important diagnostic sign to detect high-risk individuals with a history of unexplained syncope. ICD implantation plus amiodarone is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695469     DOI: 10.1111/j.1540-8167.2000.tb00743.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  55 in total

Review 1.  The electrocardiographic early repolarization pattern in athletes: normal variant or sudden death risk factor?

Authors:  Varsha Keelara Tanguturi; Peter A Noseworthy; Christopher Newton-Cheh; Aaron L Baggish
Journal:  Sports Med       Date:  2012-05-01       Impact factor: 11.136

Review 2.  ECG repolarization syndrome abnormalities (J wave syndromes) and idiopathic ventricular fibrillation: diagnostic and management.

Authors:  Samuel Lévy; Pascal Sbragia
Journal:  J Interv Card Electrophysiol       Date:  2011-07-21       Impact factor: 1.900

Review 3.  Early repolarization syndrome: A cause of sudden cardiac death.

Authors:  Abdi Ali; Nida Butt; Azeem S Sheikh
Journal:  World J Cardiol       Date:  2015-08-26

Review 4.  ECG repolarization waves: their genesis and clinical implications.

Authors:  Thinn Hlaing; Tara DiMino; Peter R Kowey; Gan-Xin Yan
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

Review 5.  Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

6.  The J Wave Syndromes and their Role in Sudden Cardiac Death.

Authors:  Dongqi Wang; Gan-Xin Yan; Charles Antzelevitch
Journal:  Card Electrophysiol Clin       Date:  2011-03-01

7.  Occurrence of "J waves" in 12-lead ECG as a marker of acute ischemia and their cellular basis.

Authors:  Rituparna Shinde; Shinde Rituparna; Suresh Shinde; Shinde Suresh; Chandrashekhar Makhale; Makhale Chandrashekhar; Purvez Grant; Grant Purvez; Sunil Sathe; Sathe Sunil; Manuel Durairaj; M Durairaj; Yash Lokhandwala; Lokhandwala Yash; Jose Di Diego; J M DI Diego; Charles Antzelevitch; Antzelevitch Charles
Journal:  Pacing Clin Electrophysiol       Date:  2007-06       Impact factor: 1.976

Review 8.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

9.  A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome.

Authors:  Kirstine Calloe; Jonathan M Cordeiro; José M Di Diego; Rie S Hansen; Morten Grunnet; Søren Peter Olesen; Charles Antzelevitch
Journal:  Cardiovasc Res       Date:  2008-12-10       Impact factor: 10.787

10.  ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.

Authors:  Dan Hu; Hector Barajas-Martínez; Andre Terzic; Sungjo Park; Ryan Pfeiffer; Elena Burashnikov; Yuesheng Wu; Martin Borggrefe; Christian Veltmann; Rainer Schimpf; John J Cai; Gi-Byong Nam; Pramod Deshmukh; Melvin Scheinman; Mark Preminger; Jonathan Steinberg; Angélica López-Izquierdo; Daniela Ponce-Balbuena; Christian Wolpert; Michel Haïssaguerre; José Antonio Sánchez-Chapula; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2014-01-04       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.